Patent application number | Description | Published |
20080318981 | Novel Compounds 480 - There are disclosed novel 5,7-disubstituted [1,3]thiazolo[4,5-d]pyrimidin-2(3H)-one derivatives of formula (I) | 12-25-2008 |
20090131468 | Bis-(Sulfonylamino) Derivatives in Therapy 065 - The invention provides compounds of formula | 05-21-2009 |
20090281138 | Bis-(Sulfonylamino) Derivatives in Therapy 066 - The invention provides compounds of formula | 11-12-2009 |
20100035899 | 5,7-DISUBSTITUTED[1.3]THIAZOLO[4,5-d]PYRIMIDIN-2(3H)-AMINE DERIVATIVES AND THEIR USE IN THERAPY - There are disclosed novel 5-substituted 7-amino-[1,3]thiazolo[4,5-d]pyrimidine derivatives of formula (I) wherein R | 02-11-2010 |
20100292279 | Bis-(Sulfonylamino) Derivatives in Therapy - The invention provides compounds of formula | 11-18-2010 |
20110021540 | Bis-(Sulfonylamino) Derivatives in Therapy 066 - The invention provides compounds of formula wherein R | 01-27-2011 |
20110059992 | New Compounds - This invention relates to novel compounds having the structural formula I below: | 03-10-2011 |
20110105537 | 5,7-DISUBSTITUTED THIAZOLO[4,5-D]PYRIMIDINES FOR THE SELECTIVE INHIBITION OF CHEMOKINE RECEPTORS - There are disclosed novel 5,7-disubstituted [1,3]thiazolo[4,5-d]pyrimidin-2(3H)-one derivatives of formula (I) | 05-05-2011 |
20120165347 | Compounds and their use as BACE Inhibitors - The present invention relates to compounds of formula (I) and their pharmaceutical compositions. In addition, the present invention relates to therapeutic methods for the treatment and/or prevention of Aβ-related pathologies such as Down's syndrome, β-amyloid angiopathy such as but not limited to cerebral amyloid angiopathy or hereditary cerebral hemorrhage, disorders associated with cognitive impairment such as but not limited to MCI (“mild cognitive impairment”), Alzheimer's disease, memory loss, attention deficit symptoms associated with Alzheimer's disease, neurodegeneration associated with diseases such as Alzheimer's disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration. | 06-28-2012 |